List of TDR-supported peer-reviewed publications 2014 · 1 | P a g e List of TDR-supported peer-reviewed publications 2014 (Retrieved from Web of Science and PubMed) Table of Contents

1 | P a g e

List of TDR-supported peer-reviewed publications 2014 (Retrieved from Web of Science and PubMed)

Table of Contents

Chagas disease ...................................................................................................................... 2

Community research ............................................................................................................. 2

Diagnosis ............................................................................................................................... 3

Dengue.................................................................................................................................. 4

Ebola ..................................................................................................................................... 4

Environment ......................................................................................................................... 4

Implementation/operational research ................................................................................... 4

Knowledge management ....................................................................................................... 5

Leishmaniasis ........................................................................................................................ 5

Leprosy ................................................................................................................................. 6

Lymphatic filariasis ................................................................................................................ 6

Malaria ................................................................................................................................. 7

Onchocerciasis ...................................................................................................................... 9

Prevention .......................................................................................................................... 10

Research capacity strengthening.......................................................................................... 10

Schistosomiasis ................................................................................................................... 10

Social research .................................................................................................................... 11

Treatment ........................................................................................................................... 11

Tuberculosis ........................................................................................................................ 12

Trypanosomiasis, human African ......................................................................................... 16

Other .................................................................................................................................. 17

2 | P a g e

Chagas disease

1. Bezerra, C. M., Cavalcanti, L. P. D., de Souza, R. D. M., Barbosa, S. E., Xavier, S. C. D., Jansen, A. M., Ramalho, R. D., and Diotaiuti, L. Domestic, peridomestic and wild hosts in the transmission of Trypanosoma cruzi in the Caatinga area colonised by Triatoma brasiliensis. Memorias do Instituto Oswaldo Cruz 109[7], 887-898. 2014. Univ Fed Ceara, Programa Posgrad Saude Comunitaria, Fortaleza, Ceara, Brazil. PubMed

2. Bustamante, D. M., De Urioste-Stone, S. M., Juarez, J. G., and Pennington, P. M. Ecological, Social and Biological Risk Factors for Continued Trypanosoma cruzi Transmission by Triatoma dimidiata in Guatemala. Plos One 9[8]. 2014. San Carlos University, Dept Biol, Guatemala City, Guatemala. PubMed

3. Cardinal, M. V., Orozco, M. M., Enriquez, G. F., Ceballos, L. A., Gaspe, M. S., varado-Otegui, J. A., Gurevitz, J. M., Kitron, U., and Gurtler, R. E. Heterogeneities in the Ecoepidemiology of Trypanosoma cruzi Infection in Rural Communities of the Argentinean Chaco. American Journal of Tropical Medicine and Hygiene 90[6], 1063-1073. 2014. University of Buenos Aires, Dept Ecol Genet & Evoluc, Lab Ecoepidemiol, RA-1428 Buenos Aires, DF, Argentina. PubMed

4. Carvajal, G., Picollo, M. I., and Toloza, A. C. Is imidacloprid an effective alternative for controlling pyrethroid-resistant populations of Triatoma infestans (Hemiptera: Reduviidae) in the Gran Chaco ecoregion? Memorias do Instituto Oswaldo Cruz 109[6], 761-766. 2014. Consejo Nacl Invest Cient & Tecn, Ctr Invest Plagas & Insecticidas, Inst Invest Cient Tecn Defensa, RA-1033 Buenos Aires, DF, Argentina. PubMed

5. Cosentino, R. O. and Aguero, F. Genetic Profiling of the Isoprenoid and Sterol Biosynthesis Pathway Genes of Trypanosoma cruzi. Plos One 9[5]. 2014. University of San Martin, CONICET, Inst Invest Biotecnol, Inst Tecnol Chascomus, Buenos Aires, DF, Argentina. PubMed

6. Enriquez, G. F., Bua, J., Orozco, M. M., Wirth, S., Schijman, A. G., Gurtler, R. E., and Cardinal, M. V. High levels of Trypanosoma cruzi DNA determined by qPCR and infectiousness to Triatoma infestans support dogs and cats are major sources of parasites for domestic transmission. Infection Genetics and Evolution 25, 36-43. 2014. University of Buenos Aires, Fac Exact & Nat Sci, Lab Ecoepidemiol, RA-1428 Buenos Aires, DF, Argentina. PubMed

7. Germano, M., Picollo, M. I., Spillmann, C., and Mougabure-Cueto, G. Fenitrothion: an alternative insecticide for the control of deltamethrin-resistant populations of Triatoma infestans in northern Argentina. Medical and Veterinary Entomology 28[1], 21-25. 2014. CONICET CITEDEF, Ctr Invest Plagas & Insecticidas, Buenos Aires, DF, Argentina. PubMed

8. Mota, T., Vitta, A. C. R., Lorenzo-Figueiras, A. N., Barezani, C. P., Zani, C. L., Lazzari, C. R., Diotaiuti, L., Jeffares, L., Bohman, B., and Lorenzo, M. G. A Multi-species Bait for Chagas Disease Vectors. Plos Neglected Tropical Diseases 8[2]. 2014. CPqRR FIOCRUZ, Lab Triatomineos & Epidemiol Doenca Chagas, Belo Horizonte, MG, Brazil. PubMed

9. Poveda, C., Fresno, M., Girones, N., Martins, O. A., Ramirez, J. D., Santi-Rocca, J., Marin-Neto, J. A., Morillo, C. A., Rosas, F., and Guhl, F. Cytokine Profiling in Chagas Disease: Towards Understanding the Association with Infecting Trypanosoma cruzi Discrete Typing Units (A BENEFIT TRIAL Sub-Study). Plos One 9[3]. 2014. Universtiy of Los Andes, Fac Ciencias, Ctr Invest Microbiol & Parasitol, Bogota, Colombia. PubMed

10. Rosecrans, K., Cruz-Martin, G., King, A., and Dumonteil, E. Opportunities for Improved Chagas Disease Vector Control Based on Knowledge, Attitudes and Practices of Communities in the Yucatan Peninsula, Mexico. Plos Neglected Tropical Diseases 8[3]. 2014. University of Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Lab Parasitol, Merida, Yucatan, Mexico. PubMed

11. Yevstigneyeva, V., Camara-Mejia, J., and Dumonteil, E. Analysis of Children's Perception of Triatomine Vectors of Chagas Disease through Drawings: Opportunities for Targeted Health Education. Plos Neglected Tropical Diseases 8[10]. 2014. University of Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Lab Parasitol, Merida, Yucatan, Mexico. PubMed

Community research

1. Abbey, M., Bartholomew, L. K., Nonvignon, J., Chinbuah, M. A., Pappoe, M., Gyapong, M., Gyapong, J. O., Bart-Plange, C., and van den Borne, B. Factors related to retention of community health workers in a trial on community-based management of fever in children under 5 years in the Dangme West District of Ghana. International Health 6[2], 99-105. 2014. Ghana Hlth Serv, Res & Dev Div, PM Bag 190, Accra, Ghana. PubMed

http://www.ncbi.nlm.nih.gov/pubmed/25410992












3 | P a g e

2. Adie, H., Igbang, T., Otu, A., Braide, E., Okon, O., Ikpi, E., Joseph, C., Desousa, A., and Sommerfeld, J. Strengthening primary healthcare through community involvement in Cross River State, Nigeria: a descriptive study. Pan Afr.Med.J. 17, 221. 2014. Ministry of Health, Calabar, Nigeria. PubMed

3. Bhutta, Z. A., Salam, R. A., Das, J. K., and Lassi, Z. S. Tackling the existing burden of infectious diseases in the developing world: existing gaps and the way forward. Infect.Dis.Poverty. 3, 28. 2014. Center of Excellence in Women & Child Health, The Aga Khan University, Karachi, Pakistan. PubMed

4. Bhutta, Z. A., Sommerfeld, J., Lassi, Z. S., Salam, R. A., and Das, J. K. Global burden, distribution, and interventions for infectious diseases of poverty. Infect.Dis.Poverty. 3, 21. 2014. Center of Excellence in Women & Child Health, The Aga Khan University, Karachi, Pakistan. PubMed

5. Das, J. K., Salam, R. A., Arshad, A., Maredia, H., and Bhutta, Z. A. Community based interventions for the prevention and control of Non-Helmintic NTD. Infect.Dis.Poverty. 3, 24. 2014. Division of Women & Child Health, The Aga Khan University, Karachi, Pakistan PubMed

6. Geoffroy, E., Harries, A. D., Bissell, K. Schell, E., Bvumbwe, A., Tayler-Smith, K., Kizito, W. Bringing care to the community: expanding access to health care in rural Malawi through mobile health clinics. Pub. Health Action 4(4): 252–258, 2014. Global AIDS Interfaith Alliance, San Francisco, California, United States of America, and Limbe, Malawi. PHA

7. Lassi, Z. S., Salam, R. A., Das, J. K., and Bhutta, Z. A. The conceptual framework and assessment methodology for the systematic reviews of community-based interventions for the prevention and control of infectious diseases of poverty. Infect.Dis.Poverty. 3, 22. 2014. Division of Women and Child Health, The Aga Khan University, Karachi, Pakistan. PubMed

8. Salam, R. A., Haroon, S., Ahmed, H. H., Das, J. K., and Bhutta, Z. A. Impact of community-based interventions on HIV knowledge, attitudes, and transmission. Infect.Dis.Poverty. 3, 26. 2014. Division of Women and Child Health, Aga Khan University, Karachi, Pakistan PubMed

9. Salam, R. A., Maredia, H., Das, J. K., Lassi, Z. S., and Bhutta, Z. A. Community-based interventions for the prevention and control of helmintic neglected tropical diseases. Infect.Dis.Poverty. 3, 23. 2014. Division of Women and Child Health, The Aga Khan University, Karachi 74800, Pakistan PubMed

Diagnosis

1. Adam, O., Ali, A. K. M., Hubschen, J. M., and Muller, C. P. Identification of congenital rubella syndrome in Sudan. Bmc Infectious Diseases 14. 2014. Natl Res Ctr, Commiss Biotechnol & Genet Engn, Dept Med Biotechnol, Khartoum, Sudan. PubMed

2. Balak, D. A., Bissell, K., Roseveare, C., Ram, S., Devi, R. R., Graham S. M. Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji. J. Trop. Med. 2014:715363, 2014. Reproductive Health Clinic, Ministry of Health, P.O. Box 30, Suva, Fiji. PubMed

3. Balak, D. A., Bissell, K., Roseveare, C., Ram, S., Devi, R. R., Graham S. M. Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji. J. Trop. Med. 2014:715363, 2014. Reproductive Health Clinic, Ministry of Health, P.O. Box 30, Suva, Fiji. PubMed

4. Benzaken, A. S., Bazzo, M. L., Galban, E., Pinto, I. C. P., Nogueira, C. L., Golfetto, L., Benzaken, N. S., Sollis, K. A., Mabey, D., and Peeling, R. W. External quality assurance with dried tube specimens (DTS) for point-of-care syphilis and HIV tests: experience in an indigenous populations screening programme in the Brazilian Amazon. Sexually Transmitted Infections 90[1], 14-18. 2014. UNAIDS, Brasilia, DF, Brazil. PubMed

5. Joseph, S. J., Li, B., Ghonasgi, T., Haase, C. P., Qin, Z. H. S., Dean, D., and Read, T. D. Direct Amplification, Sequencing and Profiling of Chlamydia trachomatis Strains in Single and Mixed Infection Clinical Samples. Plos One 9[6]. 2014. Emory University, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 United States of America. PubMed

6. Sweeney, S., Mosha, J. F., Terris-Prestholt, F., Sollis, K. A., Kelly, H., Changalucha, J., and Peeling, R. W. The costs of accessible quality assured syphilis diagnostics: informing quality systems for rapid syphilis tests in a Tanzanian setting. Health Policy and Planning 29[5], 633-641. 2014. London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London WC1H 9SH, United Kingdum. PubMed

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&dopt=citation&list_uids=25237418




http://dx.doi.org/10.5588/pha.14.0064










4 | P a g e

Dengue

1. Bowman, L. R., Runge-Ranzinger, S., and Mccall, P. J. Assessing the relationship between vector indices and dengue transmission: a systematic review of the evidence. PLoS.Negl.Trop.Dis. 8[5], e2848. 2014. Liverpool School of Tropical Medicine, Liverpool, United Kingdom. PubMed

2. Garcia-Betancourt, T., Gonzalez-Uribe, C., Quintero, J., and Carrasquilla, G. Ecobiosocial Community Intervention for Improved Aedes aegypti Control Using Water Container Covers to Prevent Dengue: Lessons Learned from Girardot Colombia. Ecohealth 11[3], 434-438. 2014. Ctr Estudios & Invest Salud CEIS Fdn Santa Fe Bog, Carrera 7B 123 90 Piso 3, Bogota, Colombia. PubMed

3. Hunsperger, E. A., Yoksan, S., Buchy, P., Nguyen, V. C., Sekaran, S. D., Enria, D. A., Vazquez, S., Cartozian, E., Pelegrino, J. L., Artsob, H., Guzman, M. G., Olliaro, P., Zwang, J., Guillerm, M., Kliks, S., Halstead, S., Peeling, R. W., and Margolis, H. S. Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody. PLoS.Negl.Trop.Dis. 8[10], e3171. 2014. Dengue Branch, Centers for Diseases Control and Prevention, San Juan, Puerto Rico, United States of America. PubMed

4. Jones, C. H., itez-Valladares, D., Guillermo-May, G., Dzul-Manzanilla, F., Che-Mendoza, A., Barrera-Perez, M., Selem-Salas, C., Chable-Santos, J., Sommerfeld, J., Kroeger, A., O'Dempsey, T., Medina-Barreiro, A., and Manrique-Saide, P. Use and acceptance of long lasting insecticidal net screens for dengue prevention in Acapulco, Guerrero, Mexico. BMC.Public Health 14, 846. 2014. Universidad Autonoma de Yucatan, Carretera Merida-Xmatkuil Km, 15,5, Merida C,P, 97315, Mexico.PubMed

5. Quintero, J., Brochero, H., Manrique-Saide, P., Barrera-Perez, M., Basso, C., Romero, S., Caprara, A., De Lima Cunha, J. C., Beltran-Ayala, E., Mitchell-Foster, K., Kroeger, A., Sommerfeld, J., and Petzold, M. Ecological, biological and social dimensions of dengue vector breeding in five urban settings of Latin America: a multi-country study. BMC.Infect.Dis. 14, 38. 2014. Centro de Estudios e Investigacion en Salud - CEIS, Fundacion Santa Fe de Bogota, Bogota, Colombia. PubMed

6. Runge-Ranzinger, S., Mccall, P. J., Kroeger, A., and Horstick, O. Dengue disease surveillance: an updated systematic literature review. Tropical Medicine & International Health 19[9], 1116-1160. 2014. Special Programme on Research and Training in Tropical Diseases (TDR), a co-sponsored programme of UNICEF/UNDP/World Bank/WHO, based at the World Health Organization, Geneva, Switzerland. PubMed

Ebola

1. Adebamowo, C., Bah-Sow, O., Binka, F., Bruzzone, R., Caplan, A., Delfraissy, J. F., Heymann, D., Horby, P., Kaleebu, P., Tamfum, J. J., Olliaro, P., Piot, P., Tejan-Cole, A., Tomori, O., Toure, A., Torreele, E., and Whitehead, J. Randomised controlled trials for Ebola: practical and ethical issues. Lancet 384[9952], 1423-1424. 18-10-2014. National Health Research Ethics Committee, Abuja, Nigeria. PubMed

2. Olliaro, P., Lasry, E., and Tiffany, A. Out of (West) Africa-Who Lost in the End? Am.J.Trop.Med.Hyg. 15-12-2014. UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland; PubMed

Environment

1. Buys, L., Aird, R., van, Megen K., Miller, E., and Sommerfeld, J. Perceptions of climate change and trust in information providers in rural Australia. Public Underst.Sci. 23[2], 170-188. 2014. Queensland University of Technology, Australia. PubMed

Implementation/operational research

1. Bullen, C., van Griensven, J. Operational research in the South Pacific. Pub. Health Action 4(2): S1, 2014. National Institute for Health Innovation, The University of Auckland, Auckland, New Zealand. PHA

2. Quaglio, G., Ramsay, A., Harries, A. D., Karapiperis, T., Putoto, G., Dye, C., Olesen, O. F., Tomson, G., and Zachariah, R. Calling on Europe to support operational research in low-income and middle-income countries. Lancet Glob.Health 2[6], e308-e310. 2014. Science and Technology Option Assessment (STOA), Directorate-General for Parliamentary Research Services (EPRS), European Parliament, Brussels, Belgium. PubMed












5 | P a g e

3. Ramsay, A., Harries, A. D., Zachariah, R., Bissell, K., Hinderaker, S. G., Edginton, M., Enarson D. A., Satyanarayana, S., Kumar, A. M. V., Hoa, N. B., Tweya, H., Reid, A. J., Van den Bergh, R., Tayler-Smith, K., Kanzi, M., Khogali, M., Kizito, W., Ali, E., Dlaunois, P., Reeder, J. C. The Structured Operational Research and Training Initiative for public health programmes. Pub. Health Action 4(2):29-84, 2014. Special Programme for Research and Training in Tropical Diseasse, World Health Organization, Geneva, Switzerland. PHA

4. Zachariah, R., Kumar, A. M. V., Reid, A. J., Van den Bergh, R., Isaakidis, P., Draguez, B., Delaunois, P., Nagaraja, S. B., Ramsay, A., Reeder, J. C., Denisiuk, O., Ali, E., Khogali, M., Hinderaker, S. G., J. Kosgei, R., van Griensven, J., Quaglio, G. L., Maher, D., Billo, N. E., Terry, R. F., Harries, A. D. Open access for operational research publications from low- and middle-income countries: who pays? Pub. Health Action 4(3): 141–144, 2014. Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg. PHA

5. Zachariah, R., Reid, T., Van den Bergh, R., Kumar, A. M. V., Tayler-Smith, K., Khogali, M., Hinderaker, S. G., Upshur, R., Harries, A. D. RE: Applying the ICMJE authorship criteria to operational research in low-income countries: the need to engage programme managers and policy makers by Zachariah et al. (2013) TMIH 18, pp. 1025–1028. Trop Med Int Health. 19(1):129-30, 2014. Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg. PubMed

Knowledge management

1. Terry, R. F., Salm, J. F., Jr., Nannei, C., and Dye, C. Creating a global observatory for health R&D. Science 345[6202], 1302-1304. 12-9-2014. Special Programme on Research and Training in Tropical Diseases (TDR), a co-sponsored programme of UNICEF/UNDP/World Bank/WHO, based at the World Health Organization, Geneva, Switzerland. PubMed

2. Young, A. J., Terry, R. F., Rottingen, J. A., and Viergever, R. F. Global biomedical R&D expenditures. N.Engl.J.Med. 370[25], 2451. 19-6-2014. Rue de l'Université, Paris, France PubMed

Leishmaniasis

1. Andrade, J. M. and Murta, S. M. F. Functional analysis of cytosolic tryparedoxin peroxidase in antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum lines. Parasites & Vectors 7. 2014. Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil. PubMed

2. Gomez, M. A., Navas, A., Marquez, R., Rojas, L. J., Vargas, D. A., Blanco, V. M., Koren, R., Zilberstein, D., and Saravia, N. G. Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival. Journal of Antimicrobial Chemotherapy 69[1], 139-149. 2014. Ctr Int Entrenamiento & Invest Med CIDEIM, Carrera 125 19-225, Cali, Colombia. PubMed

3. Ives, A., Masina, S., Castiglioni, P., Prevel, F., Revaz-Breton, M., Hartley, M. A., Launois, P., Fasel, N., and Ronet, C. MyD88 and TLR9 dependent immune responses mediate resistance to Leishmania guyanensis infections, irrespective of Leishmania RNA virus burden. PLoS.One. 9[5], e96766. 2014. Department of Biochemistry, University of Lausanne, Epalinges, Switzerland. PubMed

4. Khatun, J., Huda, M. M., Hossain, M. S., Presber, W., Ghosh, D., Kroeger, A., Matlashewski, G., and Mondal, D. Accelerated active case detection of visceral leishmaniasis patients in endemic villages of Bangladesh. PLoS.One. 9[8], e103678. 2014. Centre for Communicable Diseases, Parasitology Laboratory, icddr,b, Dhaka, Bangladesh. PubMed

5. Koutsoni, O., Barhoumi, M., Guizani, I., and Dotsika, E. Leishmania Eukaryotic Initiation Factor (LeIF) Inhibits Parasite Growth in Murine Macrophages. Plos One 9[5]. 2014. Hellenic Pasteur Inst, Dept Microbiol, Cellular Immunol Lab, Athens, Greece. PubMed

6. Maintz, E. M., Hassan, M., Huda, M. M., Ghosh, D., Hossain, M. S., Alim, A., Kroeger, A., Arana, B., and Mondal, D. Introducing single dose liposomal amphotericin B for the treatment of visceral leishmaniasis in rural bangladesh: feasibility and acceptance to patients and health staff. J.Trop.Med. 2014, 676817. 2014. Faculty of Medicine, Albert Ludwigs University, 79085 Freiburg, Germany. PubMed












6 | P a g e

7. Matlashewski, G., Arana, B., Kroeger, A., Be-Nazir, A., Mondal, D., Nabi, S. G., Banjara, M. R., Das, M. L., Marasini, B., Das, P., Medley, G., Satoskar, A., Nakhasi, H., Argaw, D., Reeder, J., and Olliaro, P. Research priorities for elimination of visceral leishmaniasis. Lancet Glob.Health 2[12], e683-e684. 2014. Department of Microbiology and Immunology, McGill University, Montreal H3A 2B4, QC, Canada. PubMed

8. Mkada-Driss, I., Lahmadi, R., Chakroun, A. S., Talbi, C., Guerbouj, S., Driss, M., Elamine, E. M., Cupolillo, E., Mukhtar, M. M., and Guizani, I. Screening and Characterization of RAPD Markers in Viscerotropic Leishmania Parasites. Plos One 9[10]. 2014. University of Tunis el Manar, Lab Epidemiol Mol & Pathol Expt LR11IPT04, Lab Epidemiol & Ecol Parasitaire LR00SP04, Inst Pasteur Tunis, Tunis, Tunisia. PubMed

9. Mondal, D., Alvar, J., Hasnain, M. G., Hossain, M. S., Ghosh, D., Huda, M. M., Nabi, S. G., Sundar, S., Matlashewski, G., and Arana, B. Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study. Lancet Glob.Health 2[1], e51-e57. 2014. International Centre For Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. PubMed

10. Pereira-Manfro, W. F., Ribeiro-Gomes, F. L., Filardy, A. A., Vellozo, N. S., Guillermo, L. V. C., Silva, E. M., Siegel, R. M., DosReis, G. A., and Lopes, M. F. Inhibition of caspase-8 activity promotes protective Th1-and Th2-mediated immunity to Leishmania major infection. Journal of Leukocyte Biology 95[2], 347-355. 2014. Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil. PubMed

11. Porta, E. O. J., Carvalho, P. B., Avery, M. A., Tekwani, B. L., and Labadie, G. R. Click chemistry decoration of amino sterols as promising strategy to developed new leishmanicidal drugs. Steroids 79, 28-36. 2014. Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Quim Rosario IQUIR CONICET, RA-2000 Rosario, Santa Fe, Argentina. PubMed

12. Salih, N. A., van Griensven, J., Chappuis, F., Antierens, A., Mumina, A., Hammam, O., Boulle, P., Alirol, E., Alnour, M., Elhag, M. S., Manzi, M., Kizito, W., Zachariah, R. Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease? Trop Med Int Health 19(2): 146–152, 2014 Médecins Sans Frontières-Switzerland, North Sudan mission, Gedaref, Sudan. PubMed

Leprosy

1. Bobosha, K., Fat, E. M. T. K., van den Eeden, S. J. F., Bekele, Y., van der Ploeg-van Schip, JJ, de Dood, C. J., Dijkman, K., Franken, K. L. M. C., Wilson, L., Aseffa, A., Spencer, J. S., Ottenhoff, T. H. M., Corstjens, P. L. A. M., and Geluk, A. Field-Evaluation of a New Lateral Flow Assay for Detection of Cellular and Humoral Immunity against Mycobacterium leprae. Plos Neglected Tropical Diseases tb8[5]. 2014. Armauer Hansen Res Inst, Addis Ababa, Ethiopia. PubMed

2. Bobosha, K., Wilson, L., van Meijgaarden, K. E., Bekele, Y., Zewdie, M., van der Ploeg-van Schip, JJ, Abebe, M., Hussein, J., Khadge, S., Neupane, K. D., Hagge, D. A., Jordanova, E. S., Aseffa, A., Ottenhoff, T. H. M., and Geluk, A. T-Cell Regulation in Lepromatous Leprosy. Plos Neglected Tropical Diseases 8[4]. 2014. Armauer Hansen Res Inst, Addis Ababa, Ethiopia. PubMed

Lymphatic filariasis

1. Bakajika, D. K., Nigo, M. M., Lotsima, J. P., Masikini, G. A., Fischer, K., Lloyd, M. M., Weil, G. J., and Fischer, P. U. Filarial Antigenemia and Loa loa Night Blood Microfilaremia in an Area Without Bancroftian Filariasis in the Democratic Republic of Congo. American Journal of Tropical Medicine and Hygiene 91[6], 1142-1148. 2014. Programme Natl Lutte Onchocercose, Kinshasa, Dem. Rep. Congo. PubMed

2. Crowther, G. J., Booker, M. L., He, M., Li, T., Raverdy, S., Novelli, J. F., He, P. Q., Dale, N. R. G., Fife, A. M., Barker, R. H., Kramer, M. L., Van Voorhis, W. C., Carlow, C. K. S., and Wang, M. W. Cofactor-Independent Phosphoglycerate Mutase from Nematodes Has Limited Drug ability, as Revealed by Two High-Throughput Screens. Plos Neglected Tropical Diseases 8[1]. 2014. University of Washington, Div Allergy & Infect Dis, Seattle, WA 98195, United States of America. PubMed

3. Moustafa, M. A., Thabet, H. S., Saad, G. A., El-Setouhy, M., Mehrez, M., and Hamdy, D. M. Surveillance of lymphatic filariasis 5 years after stopping mass drug administration in Menoufiya Governorate, Egypt. Eastern Mediterranean Health Journal 20[5], 295-299. 2014. Ain Shams University, Fac Med, Dept Med Parasitol, Cairo, Egypt. PubMed












7 | P a g e

4. Sunish, I. P., Munirathinam, A., Kalimuthu, M., Kumar, V. A., and Tyagi, B. K. Persistence of Lymphatic Filarial Infection in the Paediatric Population of Rural Community, after Six Rounds of Annual Mass Drug Administrations. Journal of Tropical Pediatrics 60[3], 245-248. 2014. Ctr Res Med Entomol ICMR, Madurai 625002, Tamil Nadu, India. PubMed

Malaria

1. Abba, K., Kirkham, A. J., Olliaro, P. L., Deeks, J. J., Donegan, S., Garner, P., and Takwoingi, Y. Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries. Cochrane.Database.Syst.Rev. 12, CD011431. 2014. Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, Merseyside, United Kingdom, L3 5QA. PubMed

2. Abdalla, H., Wilding, C. S., Nardini, L., Pignatelli, P., Koekemoer, L. L., Ranson, H., and Coetzee, M. Insecticide resistance in Anopheles arabiensis in Sudan: temporal trends and underlying mechanisms. Parasites & Vectors 7. 2014. Wits Research Institute for Malaria, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. PubMed

3. Anchang-Kimbi, J. K., Achidi, E. A., Apinjoh, T. O., Mugri, R. N., Chi, H. F., Tata, R. B., Nkegoum, B., Mendimi, J. M. N., Sverremark-Ekstrom, E., and Troye-Blomberg, M. Antenatal care visit attendance, intermittent preventive treatment during pregnancy (IPTp) and malaria parasitaemia at delivery. Malaria Journal 13. 2014. University of Buea, Dept Zool & Anim Physiol, Buea 63, Cameroon. PubMed

4. Arnold, B. F., Priest, J. W., Hamlin, K. L., Moss, D. M., Colford, J. M., and Lammie, P. J. Serological Measures of Malaria Transmission in Haiti: Comparison of Longitudinal and Cross-Sectional Methods. Plos One 9[4]. 2014. University of California Berkeley, School of Public Health, Dept. Epidemiology, Berkeley, CA 94720 United States of America. PubMed

5. Atta, H. and Reeder, J. World Malaria Day 2014: invest in the future. Defeat malaria. East Mediterr.Health J. 20[4], 219-220. 2014. Regional Adviser, Malaria Control and Elimination, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt. PubMed

6. Badejo, J. A., Abiodun, O. O., Akinola, O., Happi, C. T., Sowunmi, A., and Gbotosho, G. O. Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei. Malaria Journal 13. 2014. University of Ibadan, College of Medicine, Dept. Pharmacology & Therapeut, Ibadan, Nigeria. PubMed

7. Assogba, B. S., Djogbenou, L., Saizonou, J., Diabate, A., Dabire, R. K., Moiroux, N., Gilles, J. R. L., Makoutode, M., and Baldet, T. Characterization of swarming and mating behaviour between Anopheles coluzzii and Anopheles melas in a sympatry area of Benin. Acta Tropica 132, S53-S63. 2014. University of Abomey Calavi, Inst Reg Sante Publ, Cotonou, Benin. PubMed

8. Djegbe, I., Agossa, F. R., Jones, C. M., Poupardin, R., Cornelie, S., Akogbeto, M., Ranson, H., and Corbel, V. Molecular characterization of DDT resistance in Anopheles gambiae from Benin. Parasites & Vectors 7. 2014. University of Parakou, Ecole Normale Super Natitingou, BP 123, Parakou, Benin. PubMed

9. Dodoo, A. N. O., Fogg, C., Nartey, E. T., Ferreira, G. L. C., Adjei, G. O., Kudzi, W., Sulley, A. M., Kodua, A., and Ofori-Adjei, D. Profile of Adverse Events in Patients Receiving Treatment for Malaria in Urban Ghana: A Cohort-Event Monitoring Study. Drug Safety 37[6], 433-448. 2014. University of Ghana, School of Medicin, WHO Collaborating Ctr Advocacy & Training Pharmac, Accra, Ghana. PubMed

10. Fru-Cho, J., Bumah, V. V., Safeukui, I., Nkuo-Akenji, T., Titanji, V. P. K., and Haldar, K. Molecular typing reveals substantial Plasmodium vivax infection in asymptomatic adults in a rural area of Cameroon. Malaria Journal 13. 2014. University of Buea, Dept Microbiol & Parasitol, Buea, South West Regi, Cameroon. PubMed

11. Gaubert, A., Kauss, T., Marchivie, M., Ba, B. B., Lembege, M., Fawaz, F., Boiron, J. M., Lafarge, X., Lindegardh, N., Fabre, J. L., White, N. J., Olliaro, P. L., Millet, P., Grislain, L., and Gaudin, K. Preliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas. Int.J.Pharm. 468[1-2], 55-63. 1-7-2014. Universite de Bordeaux, EA 4575 Analytical and Pharmaceutical Developments Applied to Neglected Diseases and Counterfeits, Bordeaux, France PubMed

12. Guelbeogo, W. M., Sagnon, N., Liu, F., Besansky, N. J., and Costantini, C. Behavioural divergence of sympatric Anopheles funestus populations in Burkina Faso. Malaria Journal 13. 2014. Ctr Natl Rech & Format Paludisme, Ouagadougou 01 BP 2208, Ouagadougou, Burkina Faso. PubMed














8 | P a g e

13. Ismail, H. A., Tijani, M. K., Langer, C., Reiling, L., White, M. T., Beeson, J. G., Wahlgren, M., Nwuba, R., and Persson, K. E. M. Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria. Malaria Journal 13. 2014. Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, S-17177 Stockholm, Sweden. PubMed

14. Liu, Y. B., Hsiang, M. S., Zhou, H. Y., Wang, W. M., Cao, Y. Y., Gosling, R. D., Cao, J., and Gao, Q. Malaria in overseas labourers returning to China: an analysis of imported malaria in Jiangsu Province, 2001-2011. Malaria Journal 13. 2014. Soochow Univ, Coll Med, Suzhou, Peoples R China. PubMed

15. Kwansa-Bentum, B., boagye-Antwi, F., Otchere, J., Wilson, M. D., and Boakye, D. A. Implications of low-density microfilariae carriers in Anopheles transmission areas: molecular forms of Anopheles gambiae and Anopheles funestus populations in perspective. Parasites & Vectors 7. 2014. University of Ghana, Dept Anim Biol & Conservat Sci, Accra, Ghana. PubMed

16. Maes, P., Harries, A. D., Van den Bergh, R., Noor, A., Snow, R. W., Tayler-Smith, K., Hinderaker, S. G., Zachariah, R., Allan, R. Can Timely Vector Control Interventions Triggered by Atypical Environmental Conditions Prevent Malaria Epidemics? A Case-Study from Wajir County, Kenya. PLoS One. 9(4):e92386, 2014. Medical Department, Water, Hygiene and Sanitation Unit, Médecins Sans Frontières, Operational Center Brussels, Brussels, Belgium. PubMed

17. Manyando, C., Njunju, E. M., Chileshe, J., Siziya, S., and Shiff, C. Rapid diagnostic tests for malaria and health workers' adherence to test results at health facilities in Zambia. Malaria Journal 13. 2014. Trop Dis Res Ctr, Ndola, Zambia. PubMed

18. Matovu, F., Nanyiti, A., and Rutebemberwa, E. Household health care-seeking costs: experiences from a randomized, controlled trial of community-based malaria and pneumonia treatment among under-fives in eastern Uganda. Malaria Journal 13. 2014. Makerere University, Sch Econ, POB 7062, Kampala, Uganda. PubMed

19. Mitchell, S. N., Rigden, D. J., Dowd, A. J., Lu, F., Wilding, C. S., Weetman, D., Dadzie, S., Jenkins, A. M., Regna, K., Boko, P., Djogbenou, L., Muskavitch, M. A. T., Ranson, H., Paine, M. J. I., Mayans, O., and Donnelly, M. J. Metabolic and Target-Site Mechanisms Combine to Confer Strong DDT Resistance in Anopheles gambiae. Plos One 9[3]. 2014. University of Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England. PubMed

20. Mpogoro, F. J., Matovelo, D., Dosani, A., Ngallaba, S., Mugono, M., and Mazigo, H. D. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania. Malaria Journal 13. 2014. Catholic University of Health & Allied Sciences, Bugando, School of Public Health, POB 1464, Mwanza, Tanzania. PubMed

21. Nyunt, M. H., Aye, K. M., Kyaw, M. P., Kyaw, T. T., Hlaing, T., Oo, K., Zaw, N. N., Aye, T. T., and San, N. A. Challenges in universal coverage and utilization of insecticide-treated bed nets in migrant plantation workers in Myanmar. Malaria Journal 13. 2014. Dept Med Res, Lower Myanmar, Yangon, Myanmar. PubMed

22. Ouattara, A. F., Dagnogo, M., Constant, E. A., Kone, M., Raso, G., Tanner, M., Olliaro, P. L., Utzinger, J., and Koudou, B. G. Transmission of malaria in relation to distribution and coverage of long-lasting insecticidal nets in central Cote d'Ivoire. Malar.J. 13, 109. 2014. Centre Suisse de Recherches Scientifiques en Cote d'Ivoire, 01 BP 1303, Abidjan 01, Cote d'Ivoire. PubMed

23. Ouattara, A. F., Dagnogo, M., Olliaro, P. L., Raso, G., Tanner, M., Utzinger, J., and Koudou, B. G. Plasmodium falciparum infection and clinical indicators in relation to net coverage in central Cote d'Ivoire. Parasit.Vectors. 7, 306. 2014. Departement Environnement et Sante, Centre Suisse de Recherches Scientifiques en Cote d'Ivoire, 01 BP 1303, Abidjan 01, Cote d'Ivoire. PubMed

24. Pates, H. V., Curtis, C. F., and Takken, W. Hybridization studies to modify the host preference of Anopheles gambiae. Medical and Veterinary Entomology 28, 68-74. 2014. Wageningen University, Entomol Lab, NL-6700 EH Wageningen, Netherlands. PubMed

25. Reuter, S. E., Upton, R. N., Evans, A. M., Navaratnam, V., and Olliaro, P. L. Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria. J.Antimicrob.Chemother. 4-11-2014. School of Pharmacy & Medical Sciences, University of South Australia, Adelaide, SA, Australia. PubMed

26. Salam, R. A., Das, J. K., Lassi, Z. S., and Bhutta, Z. A. Impact of community-based interventions for the prevention and control of malaria on intervention coverage and health outcomes for the prevention and control of malaria. Infect.Dis.Poverty. 3, 25. 2014. Division of Women and Child Health, The Aga Khan University, Karachi, Pakistan PubMed




http://www.ncbi.nlm.nih.gov/pubmed/?term=Can+Timely+Vector+Control+Interventions+Triggered+by+Atypical+Environmental+Conditions+Prevent+Malaria+Epidemics%3F+A+Case-Study+from+Wajir+County%2C+Kenya.












9 | P a g e

27. Sama, W., Ajaiyeoba, E. O., and Choudhary, M. I. Larvicidal Properties of Simalikalactone D from Quassia Africana (Simaroubaceae) Baill and Baill, on the Malaria Vector Anopheles Gambiae. African Journal of Traditional Complementary and Alternative Medicines 11[4], 84-88. 2014. Catholic University of Cameroon CATUC, Sch Hlth Med Sci, Dept Pharm, Bamenda, Cameroon. PubMed

28. Sawadogo, P. S., Namountougou, M., Toe, K. H., Rouamba, J., Maiga, H., Ouedraogo, K. R., Baldet, T., Gouagna, L. C., Kengne, P., Simard, F., Costantini, C., Gibson, G., Diabate, A., Lees, R. S., Gilles, J. R. L., and Dabire, K. R. Swarming behaviour in natural populations of Anopheles gambiae and An. coluzzii: Review of 4 years survey in rural areas of sympatry, Burkina Faso (West Africa). Acta Tropica 132, S42-S52. 2014. Ctr Muraz, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso. PubMed

29. Scott, S., Mens, P. F., Tinto, H., Nahum, A., Ruizendaal, E., Pagnoni, F., Grietens, K. P., Kendall, L., Bojang, K., Schallig, H., and D'Alessandro, U. Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trial. Trials 15. 2014. MRC Unit, Fajara, Gambia. PubMed

30. Tabue, R. N., Nem, T., Atangana, J., Bigoga, J. D., Patchoke, S., Tchouine, F., Fodjo, B. Y., Leke, R. G. F., and Fondjo, E. Anopheles ziemanni a locally important malaria vector in Ndop health district, north west region of Cameroon. Parasites & Vectors 7. 2014. Univ Yaounde I, Ctr Biotechnol, Natl Reference Unit Vector Control, POB 3851 Messa, Yaounde, Cameroon. PubMed

31. Umeh, R., Oguche, S., Oguonu, T., Pitmang, S., Shu, E., Onyia, J. T., Daniyam, C. A., Shwe, D., Ahmad, A., Jongert, E., Catteau, G., Lievens, M., Ofori-Anyinam, O., and Leach, A. Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: A randomized, double-blind, lot-to-lot consistency trial. Vaccine 32[48], 6556-6562. 2014. University of Nigeria, Teaching Hosp, Enugu, Nigeria. PubMed

32. Zaloumis, S. G., Tarning, J., Krishna, S., Price, R. N., White, N. J., Davis, T. M., McCaw, J. M., Olliaro, P., Maude, R. J., Kremsner, P., Dondorp, A., Gomes, M., Barnes, K., and Simpson, J. A. Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria. CPT. Pharmacometrics. Syst.Pharmacol. 3, e145. 2014. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia PubMed

33. Zani, B., Gathu, M., Donegan, S., Olliaro, P. L., and Sinclair, D. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane. Database.Syst.Rev. 1, CD010927. 2014. South African Cochrane Centre, South African Medical Research Council, P. O. Box 19070, Tygerberg, Cape Town, Western Cape, South Africa. PubMed

34. Zhou, S. S., Rietveld, A. E., Velarde-Rodriguez, M., Ramsay, A. R., Zhang, S. S., Zhou, X. N., and Cibulskis, R. E. Operational research on malaria control and elimination: a review of projects published between 2008 and 2013. Malar.J. 13, 473. 2014. National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai 200025, People’s Republic of China. PubMed

35. Vermeersch, A., Libaud-Moal, A., Rodrigues, A., White, N. J., Olliaro, P., Gomes, M., Ashley, E. A., and Millet, P. Introducing the concept of a new pre-referral treatment for severely ill febrile children at community level: a sociological approach in Guinea-Bissau. Malar.J. 13, 50. 2014. EA 4575 Developpements Analytiques et Pharmaceutiques appliques aux Maladies Negligees et aux Contrefacons, Universite Bordeaux Segalen, Bordeaux, France. PubMed

36. Zwang, J., Dorsey, G., Martensson, A., D'Alessandro, U., Ndiaye, J. L., Karema, C., Djimde, A., Brasseur, P., Sirima, S. B., and Olliaro, P. Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009. Malar.J. 13, 114. 2014. Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland. PubMed

Onchocerciasis

1. Awadzi, K., Opoku, N. O., Attah, S. K., Lazdins-Helds, J., and Kuesel, A. C. A Randomized, Single-Ascending-Dose, Ivermectin-Controlled, Double-Blind Study of Moxidectin in Onchocerca volvulus Infection. Plos Neglected Tropical Diseases 8[6]. 2014. Onchocerciasis Chemotherapy Research Center, Hohoe, Ghana. PubMed











http://www.who.int/entity/tdr/diseases-topics/onchocerciasis/en/index.html


10 | P a g e

2. Banla, M., Tchalim, S., Karabou, P. K., Gantin, R. G., Agba, A. I., Kere-Banla, A., Helling-Giese, G., Heuschkel, C., Schulz-Key, H., and Soboslay, P. T. Sustainable Control of Onchocerciasis: Ocular Pathology in Onchocerciasis Patients Treated Annually with Ivermectin for 23 Years: A Cohort Study. Plos One 9[6]. 2014. Natl Inst Hyg, Onchocerciasis Reference Lab, Sokode, Togo. PubMed

3. Metuge, J. A., Nyongbela, K. D., Mbah, J. A., Samje, M., Fotso, G., Babiaka, S. B., and Cho-Ngwa, F. Anti-Onchocerca activity and phytochemical analysis of an essential oil from Cyperus articulatus L. Bmc Complementary and Alternative Medicine 14. 2014. University of Buea, Fac Sci, ANDI Ctr Excellence, Biotechnol Unit, Buea, Cameroon. PubMed

4. Samje, M., Metuge, J., Mbah, J., Nguesson, B., and Cho-Ngwa, F. In vitro anti-Onchocerca ochengi activities of extracts and chromatographic fractions of Craterispermum laurinum and Morinda lucida. Bmc Complementary and Alternative Medicine 14. 2014. University of Bamenda, Fac Hlth Sci, Dept Biomed Sci, Bambili, Cameroon. PubMed

Prevention

1. Bucardo, F., Reyes, Y., Svensson, L., and Nordgren, J. Predominance of Norovirus and Sapovirus in Nicaragua after Implementation of Universal Rotavirus Vaccination. Plos One 9[5]. 2014. University of Leon UNAN Leon, Dept Microbiol, Leon, Nicaragua. PubMed

2. Denisiuk, O., Smyrnov, P., Kumar, A. M. V., Achanta, S., Boyko, K., Khogali, M., Naik, B., Zachariah, R. Sex, drugs and prisons: HIV prevention strategies for over 190 000 clients in Ukraine. Pub. Health Action 4(2): 96–101, 2014. International HIV/AIDS Alliance in Ukraine, 5 Dymytrova St, Building 10A, 9th floor, Kiev 03680, Ukraine. PHA

3. Khandu, L., Zachariah, R., Van den Bergh, R., Wangchuk, D., Tshering, N., Wangmo, D., Ananthakrishnan, R., Dorji, T., Satyanarayana, S. Providing a gateway to prevention and care for the most at-risk populations in Bhutan: is this being achieved? Pub. Health Action 4(1): 22–27, 2014. National HIV/AIDS & STIs Control Programme, Department of Public Health, Ministry of Health, Royal Government of Bhutan, Thimphu, Bhutan. PHA

Research capacity strengthening

1. Bates, I., Boyd, A., Aslanyan, G., and Cole, D. C. Tackling the tensions in evaluating capacity strengthening for health research in low- and middle-income countries. Health Policy Plan. 8-4-2014. Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Manchester Business School, Booth St W, Manchester, Greater Manchester M15 6PB, United Kingdom. PubMed

2. Cole, D. C., Aslanyan, G., Dunn, A., Boyd, A., and Bates, I. Dilemmas of evaluation: health research capacity initiatives. Bull.World Health Organ 92[12], 920-921. 1-12-2014. Dalla Lana School of Public Health, University of Toronto, Health Sciences Building (room 676), 155 College Street, Toronto, Ontario, M5T 3M7, Canada. PubMed

3. MV Kumar A., Zachariah, R., Satyanarayana, S., Anthony J Reid2, Rafael Van den Bergh2, Katie Tayler-Smith2, Mohammed Khogali2 and Anthony D Harries3,4Operational research capacity building using ‘The Union/MSF’ model: adapting as we go along. BMC Research Notes 7:819 2014. International Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Regional Office, New Delhi 110016, India. PubMed

4. Zachariah, R., Guillerm, N., Berger, S., Kumar, A. M., Satyanarayana, S., Bissell, K., Edginton, M., Hinderaker, S. G., Tayler-Smith, K., Van den, Bergh R., Khogali, M., Manzi, M., Reid, A. J., Ramsay, A., Reeder, J. C., and Harries, A. D. Research to policy and practice change: is capacity building in operational research delivering the goods? Trop.Med.Int.Health 19[9], 1068-1075. 2014. Medecins Sans Frontieres, Medical Department, Brussels Operational Centre, MSF-Luxembourg, Luxembourg. PubMed

Schistosomiasis

1. Kramer, C. V., Zhang, F., Sinclair, D., and Olliaro, P. L. Drugs for treating urinary schistosomiasis. Cochrane.Database.Syst.Rev. 8, CD000053. 2014. Cochrane Infectious Diseases Group, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom, L3 5QA. PubMed







http://www.who.int/entity/tdr/diseases-topics/capacity-strengthening/en/index.html






11 | P a g e

2. Liu, L., Yang, G. J., Zhu, H. R., Yang, K., and Ai, L. Knowledge of, attitudes towards, and practice relating to schistosomiasis in two subtypes of a mountainous region of the People's Republic of China. Infectious Diseases of Poverty 3. 2014. Minister of Health, Jiangsu Prov Key Lab Parasite Mol Biol, Key Lab Parasit Dis Control & Prevent, Wuxi 214064, Jiangsu, Peoples R China. PubMed

3. Naguib, F. N. M. and el Kouni, M. H. Nucleoside kinases in adult Schistosoma mansoni: Phosphorylation of pyrimidine nucleosides. Molecular and Biochemical Parasitology 194[1-2], 53-55. 2014. University of Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 United States of America. PubMed

4. Olliaro, P., Agado-Romero, P., and Keiser, J. The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer). J.Antimicrob.Chemother. 69[4], 863-870. 2014. UNICEF/UNDP/World Bank/WHO Special Programme on Research & Training in Tropical Diseases (TDR), World Health Organization, 20 Avenue Appia, CH-1211, Geneva 27, Switzerland. PubMed

5. Zwang, J. and Olliaro, P. L. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials. PLoS.Negl.Trop.Dis. 8[11], e3286. 2014. Consultant to DNDi & Independent researcher, Bangkok, Thailand. PubMed

Social research

1. Alley, C. and Sommerfeld, J. Infectious disease in times of social and ecological change. Med.Anthropol. 33[2], 85-91. 2014. Department of Sociomedical Sciences , Mailman School of Public Health, Columbia University , New York , New York , United States of America. PubMed

2. Devasenapathy, N., George, M. S., Jerath, S. G., Singh, A., Negandhi, H., Alagh, G., Shankar, A. H., and Zodpey, S. Why women choose to give birth at home: a situational analysis from urban slums of Delhi. Bmj Open 4[5]. 2014. Publ Hlth Fdn India, Indian Inst Publ Hlth Delhi, Gurgaon, Haryana, India. PubMed

Treatment

1. Bajis, S., Van den Bergh, R., De Bruycker. M., Mahama, G., Van Overloop, C., Satyanarayana, S., Bernardo, R. S., Esmati, S., Reid, A. J. Antibiotic use in a district hospital in Kabul, Afghanistan: are we overprescribing? Pub. Health Action 4(4): 259–264, 2014. Operational Centre Brussels, Médecins Sans Frontières, Rue Dupre 94, 1090 Jette, Brussels, Belgium. PHA

2. Chang, Y-P., Duo, L., Kumar, A. M. V., Achanta, S., Xue, H-M., Satyanarayana, S., Ananthakrishnan, R., Srivastava S., Qi, W., Hu, S-Y. Retention and HIV seroconversion among drug users on methadone maintenance treatment in Yunnan, China. Pub. Health Action 4(1): 28–34, 2014. The Red Cross Hospital of Yunnan Province, Kunming, Yunnan, China, 650021. PHA

3. Shankar, D., Kumar, A. M. V., Rewari, B., Kumar, S., Shastri, S., Satyanarayana, S., Ananthakrishnan, R., Nagaraja, S. B., Devi, M., Bhargava, N., Das, M., Zachariah, R. Retention in pre-antiretroviral treatment care in a district of Karnataka, India: how well are we doing? Pub. Health Action 4(4): 210–215, 2014. ART Centre District Hospital, Tumkur-572101, Karnataka, India. PHA

4. Sobry, A., Kizito, W., Van den Bergh, R., Tayler-Smith, K., Isaakidis, P., Cheti, E., Kosgei, R. J., Vandenbulcke, A., Ndegwa, Z., Reid, T. Caseload, management and treatment outcomes of patients with hypertension and/or diabetes mellitus in a primary health care programme in an informal setting. Trop Med Int. Health. 19(1):47-57, 2014. Médecins Sans Frontières, Nairobi, Kenya. PubMed

5. Sunyoto, T., Van den Bergh, R., Valles, P., Gutierrez, R., Ayada, L., Zachariah, R., Yassin, A., Hinderaker, S. G., Harries, A. D. Providing emergency care and assessing a patient triage system in a referral hospital in Somaliland: a cross-sectional study. BMC Health Services Research. 14(1):531, 2014. Médecins Sans Frontières, Operational Centre Brussels, Somaliland Mission, Hargeisa, Somaliland; Médecins Sans Frontières, Operational Centre Barcelona, Delhi, India. PubMed












12 | P a g e

Tuberculosis

1. Abeygunawardena, S. C., Sharath, B. N., Van den Bergh, R., Naik, B., Pallewatte, N., Masaima, M. N. N. Management of previously treated tuberculosis patients in Kalutara district, Sri Lanka: how are we faring? Pub. Health Action 4(2): 105–109, 2014. District Chest Clinic Kaltura 150, Sri Lanka. PHA

2. Acosta, C. D., Dadu, A., Ramsay, A., Dara, M. Drug-resistant tuberculosis in Eastern Europe: challenges and ways forward Pub. Health Action 4(3): S3–S12, 2014. WHO Regional Offi ce for Europe, Tuberculosis and Multidrugresistant,Tuberculosis Programme, UN City, 2100 Copenhagen, Denmark. PHA

3. Acosta, C. D., Rusovich, V. Harries, A. D., Ahmedov, S., van den Boom, M., Dara M. A new roadmap for childhood tuberculosis. Lancet Glob Health. 2(1):e15-7, 2014. WHO Regional Offi ce for Europe, Tuberculosis and Multidrugresistant, Tuberculosis Programme, UN City, 2100 Copenhagen, Denmark. PubMed

4. Alikhanova, N., Akhundova, I., Seyfaddinova, M., Mammadbayov, E., Mirtskulava, V., Rüsch-Gerdes, S., Bayramov, R., Suleymanova, J., Kremer, K., Dadu, A., Acosta, C. D., Harries, A. D., Dara M. First national survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis. Pub. Health Action 4(3): S17–S23, 2014. Scientific Research Institute of Lung Disease, 25/14 E Suleymanov Street, Baku, Azerbaijan. PHA

5. Alo, A., Gounder, S., Graham, S. M. Clinical characteristics and treatment outcomes of tuberculosis cases hospitalised in the intensive phase in Fiji, Pub. Health Action 4(3): 164–168, 2014. National Tuberculosis Programme, Ministry of Health Fiji, Suva, Fiji. PHA

6. Arshad, A., Salam, R. A., Lassi, Z. S., Das, J. K., Naqvi, I., and Bhutta, Z. A. Community based interventions for the prevention and control of tuberculosis. Infect.Dis.Poverty. 3, 27. 2014. Division of Women and Child Health, The Aga Khan University, 74800 Karachi, Pakistan. PubMed

7. Asante-Poku, A., Aning, K. G., Boi-Kikimoto, B., and Yeboah-Manu, D. Prevalence of bovine tuberculosis in a dairy cattle farm and a research farm in Ghana. Onderstepoort Journal of Veterinary Research 81[2]. 2014. Noguchi Memorial Institute of Medical Research, Dept. Bacteriology, Accra, Ghana. PubMed

8. Asante-Poku, A., Nyaho, M. S., Borrell, S., Comas, I., Gagneux, S., and Yeboah-Manu, D. Evaluation of Customised Lineage-Specific Sets of MIRU-VNTR Loci for Genotyping Mycobacterium tuberculosis Complex Isolates in Ghana. Plos One 9[3]. 2014. University of Ghana, Noguchi Memorial Institute of Medical Research, Dept. Bacteriology, Legon, Ghana. PubMed

9. Bissell, K., Viney, K., Brostrom, R., Gounder, S., Khogali, M., Kishore, K., Kool, B., Kumar, A. M. V., Manzi, M., Marais, B., Marks, G., Linh, N. N., Ram, S., Reid, S., Roseveare, C., Tayler-Smith, K., Van den Bergh, R., Harries, A. D. Building operational research capacity in the Pacific. Pub. Health Action 4(2): S2–S13, 2014. International Union Against Tuberculosis and Lung Disease (The Union), Paris, France; School of Population Health, the University of Auckland, Auckland PO Box 28862, Remuera, Auckland 1541, New Zealand. PHA

10. Ciobanu, A., Domente, L., Soltan, V., Bivol, S., Severin, L., Plesca, V., Van den Bergh, R., Kumar, A. M. V., de Colombani, P. Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova? Pub. Health Action 4(3): S59–S63, 2014. Chiril Draganiuc’ Institute of Phthisiopneumology, 13C Virnav St, Chisinau, Republic of Moldova 2025. PHA

11. Cox, H., Ford, N. The scourge of tuberculosis and anti-tuberculosis drug resistance in Eastern Europe. Pub. Health Action 4(3): S1–S2, 2014. Wellcome Trust Fellow, Division of Medical Microbiology and Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa. PHA

12. Das, M., Isaakidis, P., Armstrong, E., Gundipudi, N. R., Babu, R. B., Qureshi, I. A., Claes, A., Mudimanchi, A. K., Prasad, N., Mansoor, H., Abraham, S. Directly-Observed and Self-Administered Tuberculosis Treatment in a Chronic, Low-Intensity Conflict Setting in India. PLoS One. 20;9(3):e92131, 2014. Operational Research, Médecins Sans Frontières, New Delhi, Delhi, India. PubMed

13. Das, M., Isaakidis, P., Van den Bergh, R., Kumar, A. M. V., Nagaraja, S. B., Valikayath, A., Jha, S., Jadhav, B., and Ladomirska, J. HIV, multidrug-resistant TB and depressive symptoms: when three conditions collide. Global Health Action 7, 1-5. 2014. Médecins Sans Frontières, O, A-131, New Delhi 110024, India. PubMed

14. Davtyan, K., Zachariah, R., Davtyan, H., Ramsay, A., Denisiuk, O., Manzi, M., Khogali, M., Van den Bergh, R., Hayrapetyan, A., Dara, M. Performance of decentralised facilities in tuberculosis case notification and treatment success in Armenia. Pub. Health Action 4(3): S13–S16, 2014. National Tuberculosis Control Programme, Ministry of Health of Armenia, Yerevan, Armenia. PHA












http://www.ncbi.nlm.nih.gov/pubmed/?term=Directly-Observed+and+Self-Administered+Tuberculosis+Treatment+in+a+Chronic%2C+Low-Intensity+Conflict+Setting+in+India




13 | P a g e

15. Defang, R. R., Brostrom, R., Ram, S., Johnson, E., Perman, P. S. Screening for tuberculosis and LTBI in diabetes patients, Pohnpei, Federated States of Micronesia. Pub. Health Action 4(2): S53–S55, 2014. Pohnpei Tuberculosis Control Programme, Pohnpei State Department of Health Services, Kolonia, Pohnpei, Federated States of Micronesia 96978. PHA

16. Dhillon, J., Fourie, P. B., and Mitchison, D. A. Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media. Journal of Antimicrobial Chemotherapy 69[2], 437-440. 2014. University of London, Ctr Infect, London, England. PubMed

17. Djibuti, M., Mirvelashvili, E., Makharashvili, N., and Magee, M. J. Household income and poor treatment outcome among patients with tuberculosis in Georgia: a cohort study. Bmc Public Health 14. 2014. Tbilisi State Medical University, Int Sch Publ Hlth, 33 Vazha Pshavela Ave, Tbilisi 0177, Rep of Georgia. PubMed

18. Dolgusev, O., Obevzenco, N., Padalco, O., Pankrushev, S., Ramsay, A., Van den Bergh, R., Manzi, M., Denisiuk, O., Zachariah, R. Pattern of primary tuberculosis drug resistance and associated treatment outcomes in Transnistria, Moldova. Pub. Health Action 4(3): S64–S66, 2014. Organizational and Methodological Department, The Republican Tuberculosis Hospital, Apt 4, 6 Unirii St Causani, Moldova MD-4300. PHA

19. Duthie, M. S., Coler, R. N., Laurance, J. D., Sampaio, L. H., Oliveira, R. M., Sousa, A. L. M., Stefani, M. M. A., Maeda, Y., Matsuoka, M., Makino, M., and Reed, S. G. Protection against Mycobacterium leprae Infection by the ID83/GLA-SE and ID93/GLA-SE Vaccines Developed for Tuberculosis. Infection and Immunity 82[9], 3979-3985. 2014. Infect Dis Res Inst, Seattle, WA 98102 United States of America. PubMed

20. Fanai, S., Viney, K., Tarivonda, L., Roseveare, C., Tagaro, M., Marais, B. J. Profile of tuberculosis patients with delayed sputum smear conversion in the Pacific island of Vanuatu. Pub. Health Action 4(2): S19–S24, 2014. National Tuberculosis Programme, Department of Public Health, Ministry of Health, PMB 9009, Port Vila, Vanuatu. PHA

21. Fonua, L., Bissell, K., Vivili, P., Gounder, S., Hill, P. C. Sputum smear microscopy referral rates and turnaround time in the Tonga Islands. Pub. Health Action 4(2): S29–S33, 2014. Ministry of Health, Nuku’alofa, Tongatapu, Tonga. PHA

22. Galvao, T. C., Lima, C. R., Gomes, L. H. F., Pagani, T. D., Ferreira, M. A., Goncalves, A. S., Correa, P. R., Degrave, W. M., and Mendonca-Lima, L. The BCG Moreau RD16 deletion inactivates a repressor reshaping transcription of an adjacent gene. Tuberculosis 94[1], 26-33. 2014. Escola Nacl Saude Publ Sergio Arouca, Ctr Referencia Prof Helio Fraga, Bacteriol Lab, BR-22780194 Rio De Janeiro, RJ, Brazil. PubMed

23. Gehre, F., Ejo, M., Fissette, K., de, Rijk P., Uwizeye, C., Nduwamahoro, E., Goovaerts, O., Affolabi, D., Gninafon, M., Lingoupou, F. M., Barry, M. D., Sow, O., Merle, C., Olliaro, P., Ba, F., Sarr, M., Piubello, A., Noeske, J., Antonio, M., Rigouts, L., and de Jong, B. C. Shifts in Mycobacterial Populations and Emerging Drug-Resistance in West and Central Africa. PLoS.One. 9[12], e110393. 2014. Institute of Tropical Medicine (ITM), Antwerp, Belgium; Medical Research Council (MRC), The Gambia Unit, Fajara, The Gambia PubMed

24. Guillerm, N., Tayler-Smith, K., Berger, S. D., Bissell, K., Kumar, A. M. V., Ramsay, A., Reid, A. J., Zachariah, R., Harries, A. D. What happens after participants complete a Union-MSF structured operational research training course? Pub. Health Action 4(2): 89-95, 2014. International Union Against Tuberculosis and Lung Disease (The Union), Paris, France. PHA

25. Haoues, M., Refai, A., Mallavialle, A., Barbouche, M. R., Laabidi, N., Deckert, M., and Essafi, M. Forkhead box O3 (FOXO3) transcription factor mediates apoptosis in BCG-infected macrophages. Cellular Microbiology 16[9], 1378-1390. 2014. University of Tunis El Manar, Tunis, Tunisia. PubMed

26. Harries, A. D., Bianchi, L., Jensen , P. M., Pantages, M., Bissell, K., Kumar, A. M. V., Hinderaker, S. G., Tayler-Smith, K., Van den Bergh, R., van den Boogaard, W., Manzi, M., Isaakidis, P., Reid, A. J., Zachariah, R. Public Health Action for public health action. Pub. Health Action 4(3): 139–140, 2014. International Union Against Tuberculosis and Lung Disease Old Inn Cottage, Vears Lane, Colden Common Winchester SO21 1TQ, United Kingdom. PHA

27. Harries, A. D., Marais, B., Kool, B., Ram, S., Kumar, A. M. V., Gounder, S., Viney, K., Brostrom, R., Roseveare, C., Bissell, K., Reid, A. J., Zachariah, R., Hill, P. C. Mentorship for operational research capacity building: hands-on or hands-off? Pub. Health Action 4(2): S56–S58, 2014. International Union Against Tuberculosis and Lung Disease (The Union), Paris, France; London School of Hygiene & Tropical Medicine, London, United Kingdom. PHA














14 | P a g e

28. Itogo, N., Hill, P. C., Bissell, K., Harries, A. D., Viney, K., Gounder, S. Tuberculosis notifications, characteristics and treatment outcomes: urban vs. rural Solomon Islands, 2000–201. Pub. Health Action 4(2): S25–S28, 2014. Ministry of Health and Medical Services, PO Box 349 Honiara, Solomon Islands. PHA

29. Khaliaukin, A., Kumar, A. M. V., Skrahina, A., Hurevich, H., Rusovich, V., Gadoev, J., Falzon, D., Khogali, M., de Colombani, P. Poor treatment outcomes among multidrug-resistant tuberculosis patients in Gomel Region, Republic of Belarus. Pub. Health Action 4(3): S24–S28, 2014. Gomel Regional Tuberculosis Hospital, Gomel, Belarus. PHA

30. Klimuk, D., Hurevich, H., Harries, A. D., Babrukevich, A., Kremer, K., Van den Bergh, R., Acosta, C. D., Astrauko, A., Skrahina, A. Tuberculosis in health care workers in Belarus. Pub. Health Action 4(3): S29–S33, 2014. Scientific and Practical Centre for Pulmonology and Tuberculosis, Dolginovsky trackt 157, Minsk 220053, Belarus. PHA

31. Kuchukhidze, G., Kumar, A. M. V., de Colombani, P., Khogali, M., Nanava, U., Blumberg, H. M., Kempker, R. R. Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia. Pub. Health Action Pub. Health Action 4(3): S41–S46, 2014. HIV/AIDS, Hepatitis, STI & TB Surveillance Department, National Center for Disease Control and Public Health, 9 Asatiani St, Tbilisi 0177 Georgia. PHA

32. Kuksa, L., Riekstina, V., Leimane, V., Ozere, I., Skenders, G., Van den Bergh, R., Kremer, K., Acosta, C. D., Harries, A. D. Multi- and extensively drug-resistant tuberculosis in Latvia: trends, characteristics and treatment outcomes. Pub. Health Action 4(3): S47–S53, 2014. Riga Eastern Clinical, University Hospital TB and Lung Disease Clinic, Riga, Latvia. PHA

33. Kumar RS, Kumar AM, Claassens M, Banurekha VV, Sekar G, Venkatesan P, Swaminathan S. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results? Int. J. Tuberc Lung Dis 18(4):449–453, 2014. National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chennai, India. PubMed

34. Kumar, R., Goel, S., Harries, A. D., Lal, P., Singh, R. J., Kumara, A. M. V., Wilsona, N. C. How good is compliance with smoke-free legislation in India? Results of 38 subnational surveys. Int Health. 6(3):189-95. 2014. International Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Regional Office, New Delhi 110016, India. PubMed

35. Lucenko, I., Riekstina, V., Perevoscikovs, J., Mozgis, D., Khogali, M., Gadoev, J., de Colombani, P.,. Kumar, A. M. V. Treatment outcomes among drug-susceptible tuberculosis patients in Latvia, 2006–2010. Pub. Health Action 4(3): S54–S58, 2014. Infectious Diseases Surveillance and Immunization Unit, Department of Infectious Diseases Risk Analysis and Prevention, Centre for Disease Prevention and Control of Latvia, 22 Duntes Street, Riga, Latvia LV-1005. PHA

36. Lytvynenko N, Cherenko S, Feschenko Y, Pogrebna M, Senko Y, Barbova A, et al. Management of multi- and extensively drug-resistant tuberculosis in Ukraine: how well are we doing? Public Health Action. 4(4): S67-S72, 2014. F G Yanovsky National Academy of Medical Sciences of Ukraine, Kiev, Ukraine. PHA

37. Mahadeo, R., Gounder, S., Graham, S. M. Changing from single-drug to fixed-dose combinations: experience from Fiji. Pub. Health Action 4(3): 169–173, 2014. National Tuberculosis Programme, P J Twomey Hospital, Ministry of Health, Suva, Fiji. PHA

38. Merle, C. S., Fielding, K., Sow, O. B., Gninafon, M., Lo, M. B., Mthiyane, T., Odhiambo, J., Amukoye, E., Bah, B., Kassa, F., N'Diaye, A., Rustomjee, R., de Jong, B. C., Horton, J., Perronne, C., Sismanidis, C., Lapujade, O., Olliaro, P. L., and Lienhardt, C. A four-month gatifloxacin-containing regimen for treating tuberculosis. N.Engl.J.Med. 371[17], 1588-1598. 23-10-2014. The London School of Hygiene and Tropical Medicine, London; Tropical Projects, Hitchin, United Kingdom. PubMed

39. Mfinanga, S. G., Kirenga, B. J., Chanda, D. M., Mutayoba, B., Mthiyane, T., Yimer, G., Ezechi, O., Connolly, C., Kapotwe, V., Muwonge, C., Massaga, J., Sinkala, E., Kohi, W., Lyantumba, L., Nyakoojo, G., Luwaga, H., Doulla, B., Mzyece, J., Kapata, N., Vahedi, M., Mwaba, P., Egwaga, S., Adatu, F., Pym, A., Joloba, M., Rustomjee, R., Zumla, A., and Onyebujoh, P. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Lancet Infect.Dis. 14[7], 563-571. 2014. National Institute for Medical Research, Muhumbili, Tanzania PubMed

40. Mi, F., Jiang, G., Du, J., Li, L., Yue, W., Harries, A. D., Hinderaker, S. G., Lin, Y. Is resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, China. Global Health Action May 19; 7:24022 2014. Department of Research, Beijing Chest Hospital, Capital Medical University; Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China. PubMed














15 | P a g e

41. Mohammad, D., Enarson, D. A., Khalid, S. M., Taufique, R., Habibullah, H. Does task shifting in tuberculosis microscopy services to non-certified technicians in Afghanistan affect quality? Pub. Health Action 4(1): 56–59, 2014. Bangladesh Rural Advancement Committee, Afghanistan House #45, Lane-4, Butchers’ Street, Baharistan, Kart-e-Perwan, Kabul, Afghanistan. PHA

42. Gounder, A., Gounder S, Reid, S. A. Evaluation of the implementation of the Xpert® MTB/RIF assay in Fiji. Pub. Health Action 4(3): 179–183, 2014. P J Twomey Hospital, Ministry of HealthSuva, Fiji. PHA

43. Nagai, S., Robinsonc, R., Rahamefyd J. R., Randriambelosone S. J., Ranaivomananae, D. A., Razafindranaivoe, T., Rakotobed, L., Ranaivod, A., Hinderakerf S. G., Harriesgh, A. D., Zachariahi, R. Provider-initiated HIV testing and counselling for TB in low HIV prevalence settings: is it worthwhile? Trans R Soc Trop Med Hyg 108: 173–175 2014. HIV Prevention Strengthening Project, Japan International Cooperation Agency, Madagascar. PubMed

44. Narayan, N., Viney, K., Varman, S. Comparison of tuberculosis treatment outcomes by method of treatment supervision in the Fiji Islands. Pub. Health Action 4(3): 174–178, 2014. Grant Management Unit, Ministry of Health, Suva, Fiji Islands. PHA

45. Nasa, J. N., Brostrom, R., Ram, S., Kumar, A. M. V., Seremai, J., Hauma, M., Paul, I. A., Langidrik, J. R. Screening adult tuberculosis patients for diabetes mellitus in Ebeye, Republic of the Marshall Islands. Pub. Health Action 4(2): S50–S52, 2014. TB Programme, Ebeye Community Health Center, Kwajalein Atoll Health Care Services, Ebeye, Republic of the Marshall Islands. PHA

46. Nayak, P., Kumar, A. M. V., Agrawal, T. K., Chandraker, S., Nair,S. A. Same-day light-emitting diode fluorescence microscopy for the diagnosis of tuberculosis in Chhattisgarh, India. Int J. Tuberc Lung Dis. 18(6):666–670, 2014. World Health Organization Country Office for India, New Delhi. PubMed

47. Oladimeji, O., Isaakidis, P., Obasanya, O. J., Eltayeb, O., Khogali, M., Van den Bergh, R. Kumar, A. M. V., Hinderaker, S. G., Abdurrahman, S. T., Lawson, L., Cuevas, L. E. Intensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in Nigeria. PLoS One. 10;9(4):e94393, 2014. Zankli Medical Centre, Abuja, Nigeria; Liverpool School of Tropical Medicines, Pembroke Place, Liverpool, United Kingdom. PubMed

48. Prasad, P., Gounder, S., Varman, S., Viney, K. Sputum smear conversion and treatment outcomes for tuberculosis patients with and without diabetes in Fiji. Pub. Health Action 4(3): 159–163, 2014. College of Medicine, Nursing and Health Sciences, Fiji National University, Suva, Fiji Islands. PHA

49. Reddy, M., Gounder, S., Reid, S. A. Tuberculosis diagnostics in Fiji: how reliable is culture? Pub. Health Action 4(3): 184–188, 2014. National Tuberculosis Programme, Ministry of Health, Lautoka Hospital, Fiji. PHA

50. Rusovich, V., Kumar, A. M. V., Skrahina, A., Hurevich, H., Astrauko, A., de Colombani, P., Tayler-Smith, K., Dara, M., Zachariah, R. High time to use rapid tests to detect multidrug resistance in sputum smear-negative tuberculosis in Belarus. Pub. Health Action 4(4): 243–248, 2014. World Health Organization, Country Office Belarus, 28 Fabriciusa Street, Room 401, 220007, Minsk, Belarus. PHA

51. Sambrano, D., Correa, R., Almengor, P., Dominguez, A., Vega, S., and Goodridge, A. Mycobacterium tuberculosis Isolates from Single Outpatient Clinic in Panama City Exhibit Wide Genetic Diversity. American Journal of Tropical Medicine and Hygiene 91[2], 310-312. 2014. Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Biol Celular & Mol CBCME, Panama City, Panama. PubMed

52. Singla, N., Satyanarayana, S., Sachdeva, K. S., Van den Bergh, R., Reid, T., Tayler-Smith, K., Myneedu, V. P., Ali, E., Enarson, D. A., Behera, D., Sarin, R. Impact of Introducing the Line Probe Assay on Time to Treatment Initiation of MDR-TB in Delhi, India. PLoS One. 24;9(7):e102989, 2014. National Institute of Tuberculosis & Respiratory Diseases, Delhi, India. PubMed

53. Sridhar, S., Karnani, N., Connell, D. W., Millington, K. A., Dosanjh, D., Bakir, M., Soysal, A., Deeks, J., and Lalvani, A. Increased Risk of Mycobacterium Tuberculosis Infection in Household Child Contacts Exposed to Passive Tobacco Smoke. Pediatric Infectious Disease Journal 33[12], 1303-1306. 2014. University of London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, TB Res Ctr, London W2 1PG, United Kingdum. PubMed

54. Tagaro, M., Harries, A. D., Kool, B., Ram, S., Viney, K., Marais, B., Tarivonda, L. Tuberculosis case burden and treatment outcomes in children, adults and older adults, Vanuatu, 2007–2011. Pub. Health Action 4(2): S14–S18, 2014. National TB Control Programme, Port Vila, PMB 9009, Vanuatu. PHA

















16 | P a g e

55. Tamani, T., Bissell, K., Tayler- Smith, K., Gounder, S., Linh, N. N., Graham, S. M. The trend of tuberculosis cases over 60 years in Fiji’s largest treatment centre: 1950–2010. Pub. Health Action 4(1): 42–46, 2014. Health Information Unit, Ministry of Health, Suva, Fiji. PHA

56. Tharu, M. B., Harries, A. D., Goel, S., Srivastava, S., Kumar, A. M. V., Adhikari, M., Shrestha, B., Maharjan, B., Khadka, H. Screening retreatment tuberculosis patients for drug resistance in mid-west Nepal: how well are we doing? Pub. Health Action 4(1): 60–65, 2014. International Nepal Fellowship (INF-Nepal) Central Office, Pokhara, Kaski District, Nepal. PHA

57. Toit, K., Altraja, A., Acosta, C. D., Viiklepp, P., Kremer, K., Kummik, T., Danilovitš, M., Van den Bergh, R., Harries, A. D., Supply, P. A four-year nationwide molecular epidemiological study in Estonia: risk factors for tuberculosis transmission Pub. Health Action 4(3): S34–S40 , 2014. Department of Mycobacteriology, United Laboratories, Tartu University Hospital, Puusepa 1a, 50406 Tartu, Estonia. PHA

58. Xia Y., Goel S., Harries A. D., Zhang Z., Gao T., Wang L., Cheng S., Lin Y., Du X. Prevalence of extended treatment in pulmonary tuberculosis patients receiving first-line therapy and its association with recurrent tuberculosis in Beijing, China. Trans R Soc Trop Med Hyg. 108: 402–407 2014. Chinese Center for Disease Control and Prevention, 155 Changbai Road, ChangPing District, Beijing, China. PubMed

59. Yirdaw, K. D., Jerene, D., Gashu, Z., Edginton, M. E, Kumar, A. M. V., Letamo, Y., Feleke, B., Teklu, A. M., Zewdu, S., Weiss, B., Ruff, A. Beneficial Effect of Isoniazid Preventive Therapy and Antiretroviral Therapy on the Incidence of Tuberculosis in People Living with HIV in Ethiopia. PLoS One. 9(8):e104557, 2014. Clinical Department, Johns Hopkins University TSEHAI Project, Addis Ababa, Ethiopia. PubMed

Trypanosomiasis, human African

1. Aksoy, S., Attardo, G., Berriman, M., Christoffels, A., Lehane, M., Masiga, D., and Toure, Y. Human African trypanosomiasis research gets a boost: unraveling the tsetse genome. PLoS.Negl.Trop.Dis. 8[4], e2624. 2014. Yale School of Public Health, Department of Epidemiology and Public Health, New Haven, Connecticut, United States of America. PubMed

2. Brelsfoard, C., Tsiamis, G., Falchetto, M., Gomulski, L. M., Telleria, E., Alam, U., Doudoumis, V., Scolari, F., Benoit, J. B., Swain, M., Takac, P., Malacrida, A. R., Bourtzis, K., and Aksoy, S. Presence of Extensive Wolbachia Symbiont Insertions Discovered in the Genome of Its Host Glossina morsitans morsitans. Plos Neglected Tropical Diseases 8[4]. 2014. St Catharine Coll, Dept Nat Sci, St Catharine, KY, United States of America. PubMed

3. Christoffels, A., Masiga, D., Berriman, M., Lehane, M., Toure, Y., and Aksoy, S. International glossina genome initiative 2004-2014: a driver for post-genomic era research on the African continent. PLoS.Negl.Trop.Dis. 8[8], e3024. 2014. South African Medical Research Council Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Bellville, South Africa. PubMed

4. Kaba, D., Zacarie, T., M'Pondi, A. M., Njiokou, F., Bosson-Vanga, H., Krober, T., McMullin, A., Mihok, S., and Guerin, P. M. Standardising Visual Control Devices for Tsetse Flies: Central and West African Species Glossina palpalis palpalis. Plos Neglected Tropical Diseases 8[1]. 2014. Inst Natl Sante Publ, Inst Pierre Richet, Abidjan, Cote Ivoire. PubMed

5. Nyambega, B., Helbig, C., Masiga, D. K., Clayton, C., and Levin, M. J. Proteins Associated with SF3a60 in T. brucei. Plos One 9[3]. 2014. Maseno University, Dept Med Biochem, Kisumu, Kenya. PubMed

6. Oloo, F., Sciarretta, A., Mohamed-Ahmed, M. M., Krober, T., McMullin, A., Mihok, S., and Guerin, P. M. Standardizing Visual Control Devices for Tsetse Flies: East African Species Glossina fuscipes fuscipes and Glossina tachinoides. Plos Neglected Tropical Diseases 8[11]. 2014. Tsecon Consultants, Nairobi, Kenya. PubMed

7. Watanabe, J., Hattori, M., Berriman, M., et al. Genome Sequence of the Tsetse Fly (Glossina morsitans): Vector of African Trypanosomiasis. Science 344[6182], 380-386. 2014. University of Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan. PubMed





http://www.ncbi.nlm.nih.gov/pubmed/?term=Beneficial+Effect+of+Isoniazid+Preventive+Therapy+and+Antiretroviral+Therapy+on+the+Incidence+of+Tuberculosis+in+People+Living+with+HIV+in+Ethiopia.









17 | P a g e

Other

1. Dunning, J. W., Merson, L., Rohde, G. G., Gao, Z., Semple, M. G., Tran, D., Gordon, A., Olliaro, P. L., Khoo, S. H., Bruzzone, R., Horby, P., Cobb, J. P., Longuere, K. S., Kellam, P., Nichol, A., Brett, S., Everett, D., Walsh, T. S., Hien, T. T., Yu, H., Zambon, M., Ruiz-Palacios, G., Lang, T., Akhvlediani, T., Hayden, F. G., Marshall, J., Webb, S., Angus, D. C., Shindo, N., van der, Werf S., Openshaw, P. J., Farrar, J., Carson, G., and Baillie, J. K. Open source clinical science for emerging infections. Lancet Infect.Dis. 14[1], 8-9. 2014. Centre for Respiratory Infection, National Heart and Lung Institute, Imperial College London, London, United Kingdom. PubMed

2. Edwards, J. K., Thiongó, A., Van den Bergh, R., Kizito, W., Kosgei, R. J., Sobry, A., Vandenbulcke, A., Zuniga, I., Reid, A. J. Preventable but neglected: rickets in an informal settlement, Nairobi, Kenya. Pub. Health Action 4(2): 122–127, 2014. MSF-Belgium, Kenya Mission, Kibera Project PO Box 38897-00623, Parklands, Nairobi, Kenya. PHA

3. Girin, N., Brostrom, R., Ram, S., McKenzie, J., Kumar, A. M. V., Roseveare, C. Describing the burden of non-communicable disease risk factors among adults with diabetes in Wallis and Futuna. Pub. Health Action 4(2): S39–S43, 2014. Public Health Division Healthy Pacific Lifestyles Section, Secretariat of the Pacific Community, BP 5 – 98848 Noumea Cedex, New Caledonia. PHA

4. Iribagiza, M. K., Manikuzwe, A., Aquino, T., Amoroso, C., Zachariah, R., van Griensven ,J., Schneider, S., Finnegan, K., Cortas, C., Kamanzi, E., Hamon, J. K., Hedt-Gauthier, B. L. Fostering interest in research: evaluation of an introductory research seminar at hospitals in rural Rwanda. Pub. Health Action 4(4): 271–275, 2014. Partners In Health–Inshuti, Mu Buzima, PO Box 3432, Kigali, Burera District, Northern Province, Rwanda. PHA

5. Irungu, B. N., Orwa, J. A., Gruhonjic, A., Fitzpatrick, P. A., Landberg, G., Kimani, F., Midiwo, J., Erdelyi, M., and Yenesew, A. Constituents of the Roots and Leaves of Ekebergia capensis and Their Potential Antiplasmodial and Cytotoxic Activities. Molecules 19[9], 14235-14246. 2014. University of Nairobi, Dept Chem, Nairobi 00100, Kenya. PubMed

6. Jobanputra, K., Parker, L. A., Azih C., Okello, V., Maphalala, G., Jouquet, G., Kerschberger, B., Mekeidje, C., Cyr, J., Mafikudze, A., Han, W., Lujan, J., Teck, R., Antierens, A., van Griensven, J., Reid, T. Impact and Programmatic Implications of Routine Viral Load Monitoring in Swaziland. J Acquir Immune Defic Syndr. 67(1):45-51, 2014. Médecins Sans Frontières (Operational Centre Geneva), Mbabane, Swaziland. PubMed

7. Kassahun, W., Neyens, T., Molenberghs, G., Faes, C., and Verbeke, G. Marginalized multilevel hurdle and zero-inflated models for overdispersed and correlated count data with excess zeros. Statistics in Medicine 33[25], 4402-4419. 2014. Jimma University, Dept Epidemiol & Biostat, Jimma, Ethiopia. PubMed

8. Kodouda, S. F., Zachariah, R., Khogali, M., van Griensven, J., Saeed, M., Hussein Ibrahim, E., Schneider, S., Adulazeem S., El Sadig, H. A, Atta, R., Gafar Mahgoub, N., El Sony, A. I. How well are asthma treatment cards filled out in public health centres in Gazeera State, Sudan? Pub. Health Action 4(2): 116–121, 2014. The Epidemiological Laboratory, PO Box 193, Khartoum, Sudan. PHA

9. Kumar, K., Snowdon, W., Ram, S., Khan, S., Cornelius, M., Tukana, I., Reid, S. Descriptive analysis of diabetes-related amputations at the Colonial War Memorial Hospital, Fiji, 2010–2012. Pub. Health Action 4(3): 155–158, 2014. Ministry of Health Fiji, Diabetes Fiji Inc, Suva, Fiji. PHA

10. Lackovic, K., Lessene, G., Falk, H., Leuchowius, K. J., Baell, J., and Street, I. A Perspective on 10-Years HTS Experience at the Walter and Eliza Hall Institute of Medical Research - Eighteen Million Assays and Counting. Combinatorial Chemistry & High Throughput Screening 17[3], 241-252. 2014. Walter & Eliza Hall Inst Med Res, Div Syst Biol & Personalized Med, Parkville, Vic 3052, Australia. PubMed

11. Maalim, A. M., Zachariah, R., Khogali, M., Van Griensven, J., Van den Bergh, R., Tayler-Smith, K., Kizito, W., Baruani, B., Osoblee, A., Abdirahman, F., Ayada, L., Mohamed, A. H. Supporting ‘medicine at a distance’ for delivery of hospital services in war-torn Somalia: how well are we doing? Int Health. 6(1):70-3. 2014. Médecins Sans Frontières, Belgium, Somalia Mission Coordination, Nairobi, Kenya. PubMed

12. Maini, R., Van den Bergh, R., van Griensven, J., Tayler-Smith, K., Ousley, J., Carter, D., Mhatre, S., Ho, L., Zachariah, R. Picking up the bill - improving health-care utilisation in the Democratic Republic of Congo through user fee subsidisation: a before and after study. BMC Health Services Research 14:504, 2014. Department for International Development, British Embassy, 83 Ave Roi, Baudouin, Kinshasa, the Democratic Republic of Congo. PubMed

13. Marquez, C., Okiring, J., Chamie, G., Ruel, T. D., Achan, J., Kakuru, A., Kamya, M. R., Charlebois, E. D., Havlir, D. V., and Dorsey, G. Increased Morbidity in Early Childhood Among HIV-exposed Uninfected Children in Uganda is Associated with Breastfeeding Duration. Journal of Tropical Pediatrics 60[6], 434-441. 2014. San Francisco Gen Hosp, Div HIV AIDS, 995 Potrero Ave,Bldg 80,Room 424, San Francisco, CA 94103 United States of America. PubMed














18 | P a g e

14. Matoto, V., Viney, K., Roseveare, C., Colaguiri, R. B. Marais, J. Burden and spectrum of disease in people with diabetes in Tonga. Pub. Health Action 4(2): S44–S49, 2014. National Diabetes Centre, Vaiola Hospital, Nuku’alofa, Tonga. PHA

15. Mayeku, W. P., Omollo, N. I., Odalo, O. J., and Hassanali, A. Chemical composition and mosquito repellency of essential oil of Conyza newii propagated in different geographical locations of Kenya. Medical and Veterinary Entomology 28[3], 253-256. 2014. Makerere Univ, Sch Phys Sci, Dept Chem, Kampala, Uganda. PubMed

16. Mbuthia, G. W., Harries, A. D., Obala, A. A., Nyamogoba, H. D. N., Simiyu, C., Edginton, M. E., Khogali, M., Hedt-Gauthier, B. L., Otsyla, B. K. Childhood immunisation in Bungoma County, Kenya, from 2008 to 2011: need for improved uptake. Pub. Health Action 4(1): 9–11, 2014. College of Health Sciences, Moi University, Eldoret, Kenya. PHA

17. Molfino, L., Kumar, A. M. V., Isaakidis, P., Van den Bergh, R., Khogali, M., Hinderaker, S. G., Magaia, A., Lobo, S., Edwards, C. G., Walter, J. High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique. Global Health Action. 8;7:23758, 2014. Médecins Sans Frontières, Maputo, Mozambique. PubMed

18. Montoya, J. C., Rebulanan, C. L., Parungao, N. A., and Ramirez, B. A look at the ASEAN-NDI: building a regional health R&D innovation network. Infect.Dis.Poverty. 3, 15. 2014. Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD), Taguig City, Philippines. PubMed

19. Moss, D. M., Priest, J. W., Hamlin, K., Derado, G., Herbein, J., Petri, W. A., and Lammie, P. J. Longitudinal Evaluation of Enteric Protozoa in Haitian Children by Stool Exam and Multiplex Serologic Assay. American Journal of Tropical Medicine and Hygiene 90[4], 653-660. 2014. Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, 1600 Clifton Rd, Atlanta, GA 30329 United States of America. PubMed

20. Mubilgi, J. M., Hedt-Gauthier, B., Mpunga, T., Tapela, N., Okao, P., Harries, A. D., Edginton, M. E., Driscoll, C., Mugabo, L., Riviello, R., Shulman, L. N. Caring for patients with surgically resectable cancers: experience from a specialised centre in rural Rwanda. Pub. Health Action 4(2): 128–132 , 2014. Partners in Health/Inshuti Mu Buzima (IMB), Butaro Burera District, Rwanda. PHA

21. Naidu, K., Nabose, I., Ram, S., Viney, K., Graham, S. M., Bissell, K. A Descriptive Study of NosocomInfections in an Adult Intensive Care Unit in Fiji: 2011-12. Journal of Tropical Medicine. 2014:545160, 2014. College of Medicine, Nursing & Health Sciences, Fiji National University, Suva, Fiji. PubMed

22. Nasser, S. M., Cooke, G., Kranzer, K., Norris, S. L., Olliaro, P., and Ford, N. Strength of recommendations in WHO guidelines using GRADE was associated with uptake in national policy. J.Clin.Epidemiol. 13-12-2014. Division of Infectious Diseases, St Mary's Campus, Imperial College London, Paddington, London, United Kingdom. PubMed

23. Pérez, G. M., Metcalf, C., Garone, D., Coulborn, R., Harries, A. D., Hedt-Gauthier, B., Murowa, M., Mwenelupembe, G. S., Van den Bergh, R., Triviño Durán, L. HIV testing and retention in care of infants born to HIV infected women enrolled in ‘Option B+’, Thyolo, Malawi. Pub. Health Action 4(2): 102–104, 2014 Médecins Sans Frontières, Rue Dupré 94, 1090 Brussels, Belgium. PHA

24. Robertson, M. N., Ylioja, P. M., Williamson, A. E., Woelfle, M., Robins, M., Badiola, K. A., Willis, P., Olliaro, P., Wells, T. N., and Todd, M. H. Open source drug discovery - a limited tutorial. Parasitology 141[1], 148-157. 2014. School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia. PubMed

25. Shah, S., Van den Bergh, R., Van Bellinghen, B., Severy, N., Sadiq, S., Afridi, S. A., Akhtar, A., Maïkére, J., Van Overloop, C., Saeed-ur-Rehman, Bashir-ud-Din Khilji, T., Saleem-ur-Rehman, van Griensven, J., Schneider, S., Bosman, P., Guillergan, E. L. D., Dazzi, F., Zachariah,R. Offering Mental Health Services in a Conflict Affected Region of Pakistan: Who Comes, and Why? PLoS One. 9(6): e97939, 2014. Medical Department, Médecins Sans Frontières, Operational Centre Brussels, Islamabad, Punjab, Pakistan. PubMed; Correction-21 Jul 2014.

26. Siedner, M.J. Moving past the ‘pre-treatment’ era of HIV care. Pub. Health Action 4(4): 209, 2014. Harvard Medical School, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America. PHA

27. Sergeev, G., Roy, S., Jarek, M., Zapolskii, V., Kaufmann, D. E., Nandy, R. K., and Tegge, W. High-throughput screening and whole genome sequencing identifies an antimicrobially active inhibitor of Vibrio cholerae. Bmc Microbiology 14. 2014. Helmholtz Ctr Infect Res HZI, Dept Biol Chem, D-38124 Braunschweig, Germany. PubMed







http://dx/doi.org/10.5588/pha.14.0002





http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070894/

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105562/



19 | P a g e

28. Tairea, K., Kool, B., Harries, A. D., Bissell, K., Gounder, S., Hill, P. C., Avare, T., Fariu, R. Characteristics of government workers and association with diabetes and hypertension in the Cook Islands. Pub. Health Action 4(2): S34–S38, 2014. Ministry of Health, P O Box 109, Rarotonga, Cook Islands. PHA

29. Waloki, M., Roseveare, C., Tikolevu, L., Ram, S., Bissell, K. Stroke rehabilitation in Fiji: are patients receiving services? Pub. Health Action 4(3): 150–154, 2014. College of Medicine, Nursing and Health Sciences, Fiji National University, Hoodless House, Brown Street, Suva, Fiji. PHA



Documents

List of TDR-supported peer-reviewed publications 2014 · 1 | P a g e List of TDR-supported peer-reviewed publications 2014 (Retrieved from Web of Science and PubMed) Table of Contents